Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions

Completed · Phase 4

Conditions studied: Hepatic Disease

In brief

In patients with hepatic lesions, to evaluate the efficacy of contrast enhanced ultrasound compared to MRI in differentiating focal nodular hyperplasia and hepatic adenoma.

Key facts

Study ID

NCT03652636

Run by

Indiana University

People needed

47

Starts

2019-08-05

Expected to finish

2023-07-21

Last updated by the study team

2024-10-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females
• Age 18 years or greater
• Scheduled to undergo abdominal MRI with contrast at a performance site for evaluation of a hepatic lesion(s).

You may not qualify if…

• History of cardiac shunting
• History of acute cardiac ischemia
• History of hypersensitivity reaction to Lumason

Where it is running

• IU University Hospital — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.